Autoimmune Neurological Attack Claim Denied After Five Claim-Free Years: How One Family Fought Back

A family had maintained a health insurance policy continuously for five years, paying every premium on time and never filing a single claim. Then the policyholder's mother, in her early fifties, was admitted to hospital after a sudden and severe autoimmune neurological episode. Within a short period she lost vision in both eyes, could no longer walk without support, and had lost bladder and bowel control. Her treating neurologist made the decision to admit her immediately.

The reason for hospitalisation was not incidental. The patient had a pre-existing metabolic condition that made outpatient administration of high-dose immunosuppressive therapy unsafe. The neurologist set out in writing precisely why inpatient monitoring was clinically necessary, not optional. The family submitted the full set of medical records: MRI scans, specialist letters, treatment charts, and the consultant's written justification for admission.

The insurer denied the claim.

No alternative clinical reasoning was provided that engaged with the neurologist's documented position. The family was left with a denial after five years of continuous coverage and no prior claims history.

The policyholder escalated the matter, requesting that senior medical experts at the insurer conduct a fresh, evidence-based review of the file. The argument was straightforward: a specialist had documented why hospitalisation was clinically mandatory for this particular patient, and that documentation had not been meaningfully addressed in the denial.

Public attention to the case, combined with persistent escalation, prompted the insurer to reopen the file. Following a detailed medical review, the claim was approved. Two named officials at the insurer were credited with moving the matter forward once it received the appropriate level of clinical scrutiny.

This case illustrates a pattern that is far from unusual. When a condition is unfamiliar or costly, an initial denial can be issued without adequately engaging with the specialist's reasoning. The policyholder is then placed in the position of having to prove, again, what the treating doctor has already documented. The outcome here was positive, but it required public escalation to achieve what the standard review process should have delivered from the outset.

For policyholders facing a similar situation, the insurer's internal grievance mechanism is the first formal step. If the complaint is not resolved satisfactorily, the Insurance Ombudsman provides a cost-effective and impartial grievance redressal route. Complaints can also be registered through the Bima Bharosa portal, the IRDAI's integrated grievance management system.

What went wrong

• The insurer's initial medical review did not adequately engage with the treating neurologist's written justification for hospitalisation.
• The clinical complexity of high-dose immunosuppressive therapy in a patient with a concurrent metabolic condition was apparently not factored into the denial decision.
• A five-year, claim-free policyholder received no benefit of the doubt at the first point of review.
• The denial did not appear to be reviewed by a specialist of equivalent seniority to the treating neurologist.
• The family was required to escalate publicly before the insurer conducted the thorough medical review that should have occurred initially.

What evidence mattered

• Treating neurologist's written justification for inpatient admission, specifically addressing why outpatient care was not safe for this patient.
• MRI reports and imaging confirming the acute neurological episode.
• Complete inpatient medical records including treatment charts and drug administration logs.
• Specialist documentation of the patient's concurrent metabolic condition and its implications for treatment monitoring.
• Correspondence record showing the timeline of claim submission, denial, and escalation.
• Any written reasoning provided by the insurer for the initial denial, to be compared against the specialist's documented position.

The escalation route that applies

1. 1.Submit a formal written complaint to the insurer's grievance redressal officer, referencing the specific claim number and attaching all clinical documentation.
2. 2.If the insurer does not resolve the complaint satisfactorily, register a complaint on the Bima Bharosa portal, the IRDAI's integrated grievance management system.
3. 3.If the complaint is not attended to within 15 days of registration on Bima Bharosa, or if the resolution provided by the insurer is not satisfactory, approach the Insurance Ombudsman under the Insurance Ombudsman Rules, 2017.
4. 4.The Insurance Ombudsman is a quasi-judicial body that provides a cost-effective and impartial grievance redressal mechanism. For information on rules and procedures, visit the Council for Insurance Ombudsmen website.

Solvh's take

This case reflects a structural weakness in how health insurers handle first-time claims for complex, high-cost conditions. Autoimmune neurological conditions are relatively rare and involve treatment protocols, such as high-dose immunosuppressive therapy, that are expensive and not always familiar to non-specialist reviewers. When an insurer's medical team lacks depth in the relevant specialty, denials can be issued that fail to engage with the treating clinician's documented reasoning.

Several compounding factors likely contributed to the initial denial. The cost of immunosuppressive treatment is high. The condition itself may not have been well recognised by the reviewer. And because hospitalisation for autoimmune conditions can superficially resemble cases where outpatient care might be argued as sufficient, a non-specialist reviewer may reach the wrong conclusion.

What the case also reveals is the role of persistence and public visibility in correcting outcomes that the standard process should have caught earlier. The policyholder had to reframe the request explicitly as a demand for senior medical expertise, not simply a re-submission of paperwork. That reframing worked, but it should not have been necessary.

The systemic lesson is that when a treating specialist provides written clinical justification for inpatient admission, that justification deserves a response from a reviewer of equivalent or greater clinical seniority in the relevant field. A denial that does not engage with the specialist's reasoning is not a medically-informed decision. It is a process failure dressed up as one.